CELL MEDIATED IMMUNITY TO HAPTEN MODIFIED SYNGENEIC LYMPHOCYTES IN MICE
Project Number1Z01CB005038-13
Contact PI/Project LeaderSHEARER, G M
Awardee OrganizationDIVISION OF CANCER BIOLOGY AND DIAGNOSIS
Description
Abstract Text
Mouse spleen cells were modified with trinitrobenezene sulfonate (TNP), and
the TNP-self modified cells were tested in two different ways. First,
several monoclonal antibodies (mAbs) specific for class I H-2 antigens were
tested for binding to TNP-modified spleen cells. Second, the modified
cells were used as stimulator and target cells for in vitro tests for
cytotoxic T lymphocyte (CTL) responses to TNP-self. A number of anti-H-2Kk
antibodies not mAbs of other specificities exhibited enhanced binding to
cells that normally express Kk. Furthermore, these same mAbs bound to H-2b
cells modified with TNP. These results parallel the patterns of
preferential CTL recognition in H-2k mice and of crossreactive CTL in H-2b
mouse strains.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
T lymphocyteautologous transplantationcell cell interactioncell mediated cytotoxicitycell population studycell typecellular immunityclone cellscross immunitygenetic regulationgenetic strainhaptenshelper T lymphocytehistocompatibility geneimmune tolerance /unresponsivenessimmunogeneticsimmunotoxicitymajor histocompatibility complexmembrane activitymonoclonal antibodynitrobenzenespleensurface antigens
No Sub Projects information available for 1Z01CB005038-13
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1Z01CB005038-13
Patents
No Patents information available for 1Z01CB005038-13
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1Z01CB005038-13
Clinical Studies
No Clinical Studies information available for 1Z01CB005038-13
News and More
Related News Releases
No news release information available for 1Z01CB005038-13
History
No Historical information available for 1Z01CB005038-13
Similar Projects
No Similar Projects information available for 1Z01CB005038-13